Suivre
WEI ZHAO
WEI ZHAO
Postdoctoral fellow of Division of Cancer Epidemiology and Genetics, National Cancer Institute
Adresse e-mail validée de nih.gov
Titre
Citée par
Citée par
Année
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
109552012
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ...
Nature genetics 45 (10), 1113-1120, 2013
63422013
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ...
Cell 158 (4), 929-944, 2014
15122014
PARPi triggers the STING-dependent immune response and enhances the therapeutic efficacy of immune checkpoint blockade independent of BRCAness
J Shen, W Zhao, Z Ju, L Wang, Y Peng, M Labrie, TA Yap, GB Mills, ...
Cancer research 79 (2), 311-319, 2019
4622019
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
J Shen, Z Ju, W Zhao, L Wang, Y Peng, Z Ge, ZD Nagel, J Zou, C Wang, ...
Nature medicine 24 (5), 556-562, 2018
4152018
Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling
W Zhao, X He, KA Hoadley, JS Parker, DN Hayes, CM Perou
BMC genomics 15, 1-11, 2014
3482014
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells
JI Herschkowitz, W Zhao, M Zhang, J Usary, G Murrow, D Edwards, ...
Proceedings of the National Academy of Sciences 109 (8), 2778-2783, 2012
2542012
BRD4 inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency
C Sun, J Yin, Y Fang, J Chen, KJ Jeong, X Chen, CP Vellano, Z Ju, ...
Cancer cell 33 (3), 401-416. e8, 2018
2392018
Characterization of human cancer cell lines by reverse-phase protein arrays
J Li, W Zhao, R Akbani, W Liu, Z Ju, S Ling, CP Vellano, P Roebuck, Q Yu, ...
Cancer cell 31 (2), 225-239, 2017
2062017
Breast cancer quantitative proteome and proteogenomic landscape
HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ...
Nature communications 10 (1), 1600, 2019
1662019
Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer
K Xu, J Usary, PC Kousis, A Prat, DY Wang, JR Adams, W Wang, AJ Loch, ...
Cancer cell 21 (5), 626-641, 2012
1362012
Tumor evolution in two patients with basal-like breast cancer: a retrospective genomics study of multiple metastases
KA Hoadley, MB Siegel, KL Kanchi, CA Miller, L Ding, W Zhao, X He, ...
PLoS medicine 13 (12), e1002174, 2016
1222016
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ...
Breast Cancer Research 19, 1-18, 2017
1022017
Functional variomics and network perturbation: connecting genotype to phenotype in cancer
S Yi, S Lin, Y Li, W Zhao, GB Mills, N Sahni
Nature Reviews Genetics 18 (7), 395-410, 2017
982017
Explore, visualize, and analyze functional cancer proteomic data using the cancer proteome atlas
J Li, R Akbani, W Zhao, Y Lu, JN Weinstein, GB Mills, H Liang
Cancer research 77 (21), e51-e54, 2017
962017
Genomic and evolutionary classification of lung cancer in never smokers
T Zhang, P Joubert, N Ansari-Pour, W Zhao, PH Hoang, R Lokanga, ...
Nature genetics 53 (9), 1348-1359, 2021
942021
Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction
Y Sun, C Li, L Jin, P Gao, W Zhao, W Ma, M Tan, W Wu, S Duan, Y Shan, ...
European radiology 30, 3650-3659, 2020
932020
Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
X Hua, W Zhao, AC Pesatori, D Consonni, NE Caporaso, T Zhang, B Zhu, ...
Nature communications 11 (1), 2459, 2020
882020
Predicting drug responsiveness in human cancers using genetically engineered mice
J Usary, W Zhao, D Darr, PJ Roberts, M Liu, L Balletta, O Karginova, ...
Clinical Cancer Research 19 (17), 4889-4899, 2013
852013
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors
L Wang, L Yang, C Wang, W Zhao, Z Ju, W Zhang, J Shen, Y Peng, C An, ...
The Journal of clinical investigation 130 (11), 5951-5966, 2020
772020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20